Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study.

MLA

Nethander, Maria, et al. “Assessment of the Genetic and Clinical Determinants of Hip Fracture Risk: Genome-Wide Association and Mendelian Randomization Study.” Cell Reports. Medicine, vol. 3, no. 10, Oct. 2022, p. 100776. EBSCOhost, https://doi.org/10.1016/j.xcrm.2022.100776.

APA

Nethander, M., Coward, E., Reimann, E., Grahnemo, L., Gabrielsen, M. E., Wibom, C., Mägi, R., Funck-Brentano, T., Hoff, M., Langhammer, A., Pettersson-Kymmer, U., Hveem, K., & Ohlsson, C. (2022). Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study. Cell Reports. Medicine, 3(10), 100776. https://doi.org/10.1016/j.xcrm.2022.100776

Chicago

Nethander, Maria, Eivind Coward, Ene Reimann, Louise Grahnemo, Maiken E Gabrielsen, Carl Wibom, Reedik Mägi, et al. 2022. “Assessment of the Genetic and Clinical Determinants of Hip Fracture Risk: Genome-Wide Association and Mendelian Randomization Study.” Cell Reports. Medicine 3 (10): 100776. doi:10.1016/j.xcrm.2022.100776.